DiaSorin S.p.A. | Ownership
Companies that own DiaSorin S.p.A.
Threadneedle Asset Management Ltd.
1,339,682
2.4%
158
0.23%
07/31/2018
Norges Bank Investment Management
796,084
1.42%
-317,286
0.01%
04/23/2018
DWS Investment GmbH
682,888
1.22%
251,401
0.04%
07/31/2018
The Vanguard Group, Inc.
609,425
1.09%
14,281
0%
07/31/2018
Baring Asset Management Ltd.
509,348
0.91%
1,012
0.74%
01/31/2018
Schroder Investment Management Ltd.
442,716
0.79%
-25,420
0.03%
06/30/2018
Mandarine Gestion SA
275,712
0.49%
21,326
0.89%
05/31/2018
Eurizon Capital SGR SpA
256,472
0.46%
12,257
0.12%
05/31/2018
JPMorgan Asset Management (UK) Ltd.
252,335
0.45%
-68,646
0.02%
07/31/2018
Dimensional Fund Advisors LP
250,514
0.45%
26,456
0.01%
04/30/2018
| Address |
Via Crescentino snc
Saluggia Vercelli 13040
Italy
|
|
Employees
|
- |
| Website |
http://www.diasorin.com |
| Updated |
07/08/2019 |
| DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics. It specializes in the provision of immunodiagnostics and molecular diagnostics solutions which meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology and endocrinology. The company was founded in 1968 and is headquartered in Vercelli, Italy . |
